Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. The company focuses on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505(b)(2) approach). The company develops products in two therapeutic areas with great unmet needs, Parkinson’s disease and Cancer.
The Company’s leading product, P2B001 was successfully tested in a phase IIb clinical study with 149 parkinson’s disease patients in the US and Israel. The results showed a significant effect of improvement in the subjects condition according to several Parkinson’s disease scales compared to Placebo.
Pharma Two B main investors include Crossroad and JK&B.
www.pharma2b.com
Location: Israel, Center District, Rehovot
Employees: 11-50
Total raised: $38M
Founded date: 2007
Investors 4
| Date | Name | Website |
| - | Crossroad | crossroad-... |
| - | aMoon Fund | amoon.fund... |
| - | Israel Bio... | ibf.fund |
| - | JVC Invest... | jvcmanagem... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 27.02.2017 | - | $30M | - |
| 22.10.2012 | - | $8M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 15.12.2021 | Pharma Two B Announces Positive Topline Results from its Piv... | REHOVOT, Israel, Dec. 15, 2021 /PRNewswire/ -- Pharma Two B Ltd., a privately held company developin... | marketscre... |
| 27.02.2017 | Term Sheet — Monday, February 27 | MONEYBALL FOR STARTUPS Crowdfunding watch: Is it fair to say the realities of equity crowdfunding h... | fortune.co... |
| 27.02.2017 | Pharma Two B raises $30M for Parkinson's phase 3 from Biogen... | Pharma Two B has raised $30 million (€28 million) to complete a phase 3 trial of its Parkinson’s ass... | fiercebiot... |
| 27.02.2017 | Pharma Two B Completes $30M Third Financing Round | Pharma Two B Ltd., a Rehovoth, Israel-based biopharmaceutical company focused on developing treatmen... | finsmes.co... |
| 27.02.2017 | Pharma Two B Ltd. Closes $30 Million Financing Round | - | amoon.fund... |
| 23.10.2012 | Pharma Two B Raises $8M in Second Round | REHOVOTH, ISRAEL, Privately held company focused on developing Fixed-Dose-Combinations (FDCs) of t... | vcnewsdail... |
| 22.10.2012 | Pharma Two B Completes $8M Second Financing Round | Pharma Two B Ltd., a Rehovoth, Israel-based company that focuses on developing Fixed-Dose-Combinatio... | finsmes.co... |